ArticleScience immunology2024
Overexpression of
Abstract read
In one paragraph
Article in Science immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed.
- Cell cycle-dependent translation-mediated turnover of the long noncoding RNA Malat1.The Journal of cell biology · 2026Article
- Mapping malignant T-cell states and immune circuits in Sézary syndrome by single-cell analysis.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026Article
- Pathophysiological roles of monocytes and macrophages in cancer.Nature reviews. Immunology · 2026Review
- Targeting the non-coding RNA-PANoptosis axis: a novel frontier in disease diagnosis and therapy.Apoptosis : an international journal on programmed cell death · 2026Review
- Tracing of Porcine lncRNAGenes · 2026Article
- Decoding the role of polyamine metabolism in lung adenocarcinoma prognosis: A triangulated approach combining transcriptome, single-cell and Mendelian randomization analyses.Oncology letters · 2026Article
- Quercetin Affects Carcinogenic Phenotype of Breast and Lung Cancer Cells Differentially Through Sterol Regulation Mediated by MALAT1 Perturbation.Chemistry, an Asian journal · 2026Article
- The Impact of Targeting TRAF2 and NCK-Interacting Protein Kinase on Antitumor Effect and Tumor Immune Environment in c-MYC-High SCLC.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2026Article
- Multi-Omics reveals SPP1 + malignant and CXCR4Discover oncology · 2026Article
- Patient-derived organoid xenografts reveal the multifaceted role of the lncRNAbioRxiv : the preprint server for biology · 2026Article
- Intron Retention Controls Localization of lncRNAsbioRxiv : the preprint server for biology · 2026Article
- Chromatin Accessibility in Cancer: Biological Functions, Mechanisms, Therapeutic Potential, and Future Directions.MedComm · 2026Review
- Stenotrophomonas promotes gastrointestinal tumor progression via STING degradation in tumour cells and mitigated immune response.Nature communications · 2026Article
- The CCL2-CCR2 axis in primary lung cancer and pulmonary metastasis: from molecular mechanisms to therapeutic potentials.Frontiers in immunology · 2026Review
- Longitudinal tracking ofMolecular therapy. Oncology · 2025Article
- Biomolecular condensates: molecular structure, biological functions, diseases, and therapeutic targets.Molecular biomedicine · 2025Review
- MALAT1 as a molecular driver of tumor progression, immune evasion, and resistance to therapy.Molecular cancer · 2025Review
- Review
- The Interplay Between Oxidant/Antioxidant System, Transcription Factors, and Non-Coding RNA in Lung Cancer.International journal of molecular sciences · 2025Review
- Targeting LINC02320 prevents colorectal cancer growth via GRB7-dependent inhibition of MAPK signaling pathway.Cellular & molecular biology letters · 2025Article
Corrections and comments
- Update ofOverexpressed2023
Authors and funding
10 authors.
Elena Martinez-TerrobaDepartment of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT 06511, USA.ORCID 0000-0003-1956-0975
Leah M Plasek-HegdeDepartment of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT 06511, USA.ORCID 0000-0002-0161-3277
Ioannis ChiotakakosDepartment of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT 06511, USA.ORCID 0009-0007-6973-3842
Vincent LiDepartment of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, CA 90095, USA.ORCID 0009-0009-4613-4040
Fernando J de MiguelYale Cancer Center, Yale University, New Haven, CT 06511, USA.ORCID 0000-0002-5847-9371
Camila Robles-OteizaDepartments of Pathology and Internal Medicine (Section of Medical Oncology), Yale School of Medicine, New Haven, CT 06511, USA.ORCID 0000-0001-7157-9572
Antariksh TyagiYale Center for Genome Analysis, Yale University, New Haven, CT 06516, USA.ORCID 0000-0002-4662-077X
Katerina PolitiYale Cancer Center, Yale University, New Haven, CT 06511, USA.
Jesse R ZamudioDepartment of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, CA 90095, USA.ORCID 0000-0001-8714-1049
Nadya DimitrovaDepartment of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT 06511, USA.ORCID 0000-0002-5983-1496
Funding
Yale Pathology Tissue Services Shared ResourceP30CA016359 · NCI · YALE UNIVERSITY · PI Eric P. Winer · 1985 to 2026
$85.0MYale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung CancerP50CA196530 · NCI · YALE UNIVERSITY · PI Harriet M. Kluger · 2015 to 2026
$31.1MRoles and mechanisms of cis-regulatory IncRNAs in the p53 tumor suppressor pathwayR37CA230580 · NCI · YALE UNIVERSITY · PI DIMITROVA, NADYA M · 2018 to 2024
$2.5MDeregulation of long noncoding RNAs in cancerR01CA262286 · NCI · YALE UNIVERSITY · PI DIMITROVA, NADYA M · 2022 to 2025
$2.3MMechanisms of Genomic Stability by Mammalian Argonaute ProteinsR01GM143536 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ZAMUDIO, JESSE R. · 2021 to 2024
$1.3MHigh Performance Computing Instrumentation for the Yale Center for Genome AnalysisS10OD030363 · OD · YALE UNIVERSITY · PI MANE, SHRIKANT M · 2022 to 2022
$1.2MNCI NIH HHS P30 CA016359NCI NIH HHS P50 CA196530NCI NIH HHS R01 CA262286NCI NIH HHS R37 CA230580NIGMS NIH HHS R01 GM143536NIH HHS S10 OD030363
Abstract
Expression of the long noncoding RNA (lncRNA) metastasis-associated lung adenocarcinoma transcript 1 (
Indexed as
Adenocarcinoma of LungChemokine CCL2Lung NeoplasmsNeoplasm MetastasisRNA, Long NoncodingTumor MicroenvironmentAnimalsCell Line, TumorGene Expression Regulation, NeoplasticHumansInflammationMacrophagesMiceCCL2 protein, humanCcl2 protein, mouseChemokine CCL2MALAT1 long non-coding RNA, humanMalat1 long non-coding RNA, mouseRNA, Long Noncoding
Identifiers
What Socratic holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.